Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Ochsner
mi
from
New Orleans, LA
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Ochsner
mi
from
New Orleans, LA
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Duluth
mi
from
Duluth, MN
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
Coborn Cancer Center
mi
from
Saint Cloud, MN
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
Coborn Cancer Center
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
Medcenter One Health System
mi
from
Bismarck, ND
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Toledo Community Hospital
mi
from
Toledo, OH
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Toledo Community Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - St. Vincent Hospital Cancer Center, Green Bay
mi
from
Green Bay, WI
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - St. Vincent Hospital Cancer Center, Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Mayo Clinic
mi
from
Jacksonville, FL
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Duluth
mi
from
Duluth, MN
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CentraCare Health Plaza
mi
from
Saint Cloud, MN
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CentraCare Health Plaza
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Medcenter One Health System
mi
from
Bismarck, ND
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Altru Health Systems
mi
from
Grand Forks, ND
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Altru Health Systems
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Toledo Community Hospital
mi
from
Toledo, OH
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Toledo Community Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
A Phase II Study of Local Excision Alone or Local Excision Plus Adjuvant Chemoradiation Therapy for Small Distal Rectal Cancers
Status: Enrolling
Updated:  7/13/2015
Northeast Alabama Regional Medical Center
mi
from
Anniston, AL
Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
A Phase II Study of Local Excision Alone or Local Excision Plus Adjuvant Chemoradiation Therapy for Small Distal Rectal Cancers
Status: Enrolling
Updated: 7/13/2015
Northeast Alabama Regional Medical Center
mi
from
Anniston, AL
Click here to add this to my saved trials
Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
A Phase II Study of Local Excision Alone or Local Excision Plus Adjuvant Chemoradiation Therapy for Small Distal Rectal Cancers
Status: Enrolling
Updated:  7/13/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
A Phase II Study of Local Excision Alone or Local Excision Plus Adjuvant Chemoradiation Therapy for Small Distal Rectal Cancers
Status: Enrolling
Updated: 7/13/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Click here to add this to my saved trials
Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
A Phase II Study of Local Excision Alone or Local Excision Plus Adjuvant Chemoradiation Therapy for Small Distal Rectal Cancers
Status: Enrolling
Updated:  7/13/2015
CCOP - Greater Phoenix
mi
from
Phoenix, AZ
Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
A Phase II Study of Local Excision Alone or Local Excision Plus Adjuvant Chemoradiation Therapy for Small Distal Rectal Cancers
Status: Enrolling
Updated: 7/13/2015
CCOP - Greater Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
A Phase II Study of Local Excision Alone or Local Excision Plus Adjuvant Chemoradiation Therapy for Small Distal Rectal Cancers
Status: Enrolling
Updated:  7/13/2015
Veterans Affairs Medical Center - Phoenix (Carl T. Hayden)
mi
from
Phoenix, AZ
Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
A Phase II Study of Local Excision Alone or Local Excision Plus Adjuvant Chemoradiation Therapy for Small Distal Rectal Cancers
Status: Enrolling
Updated: 7/13/2015
Veterans Affairs Medical Center - Phoenix (Carl T. Hayden)
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
A Phase II Study of Local Excision Alone or Local Excision Plus Adjuvant Chemoradiation Therapy for Small Distal Rectal Cancers
Status: Enrolling
Updated:  7/13/2015
Veterans Affairs Medical Center - Tucson
mi
from
Tucson, AZ
Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
A Phase II Study of Local Excision Alone or Local Excision Plus Adjuvant Chemoradiation Therapy for Small Distal Rectal Cancers
Status: Enrolling
Updated: 7/13/2015
Veterans Affairs Medical Center - Tucson
mi
from
Tucson, AZ
Click here to add this to my saved trials